Cart
sales@molnova.com
Neuropeptide EI, rat
CAS No. 125934-45-4
Neuropeptide EI, rat( —— )
Catalog No. M30277 CAS No. 125934-45-4
Displays functional MCH-antagonist and MSH-agonist activity in different behavioral paradigms.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNeuropeptide EI, rat
-
NoteResearch use only, not for human use.
-
Brief DescriptionDisplays functional MCH-antagonist and MSH-agonist activity in different behavioral paradigms.
-
DescriptionDisplays functional MCH-antagonist and MSH-agonist activity in different behavioral paradigms.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetMelanocortin Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number125934-45-4
-
Formula Weight1447.55
-
Molecular FormulaC63H98N16O23
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameSequence:{Glu}{Ile}{Gly}{Asp}{Glu}{Glu}{Asn}{Ser}{Ala}{Lys}{Phe}{Pro}{Ile}-NH2
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
Hintermann E, et al. Interaction of melanin-concentrating hormone (MCH), neuropeptide E-I (NEI), neuropeptide G-E (NGE), and alpha-MSH with melanocortin and MCH receptors on mouse B16 melanoma cells. J Recept Signal Transduct Res. 2001 Feb;21(1):93-116.
molnova catalog
related products
-
PF-00446687
PF-00446687 (PF-446687) is a potent, selective melanocortin-4 receptor (MC4R) agonist with EC50 of 12 nM.
-
BMS-470539 dihydroch...
BMS-470539 dihydrochloride is a selective and highly potent melanocortin 1 receptor (MC-1 R) agonist with anti-inflammatory activity.
-
HS 024
Highly potent melanocortin MC4 receptor antagonist (Ki values are 0.29, 18.6, 5.45 and 3.29 nM for cloned human MC4, MC1, MC3 and MC5 receptors respectively). Increases food intake, and blocks α-MSH- and MTII-induced hypotension and bradycardia in rats, following central administration in vivo.
